Singular Genomics Systems Inc reports results for the quarter ended in March - Earnings Summary

Singular Genomics Systems

09/05/2023 23:36

* Singular Genomics Systems Inc  OMIC.OQ  reported a
quarterly
adjusted loss of 33 cents​​ per share for the quarter ended in
March. The mean expectation of five analysts for the quarter was
for a loss of 35 cents per share.
    * Revenue was $863.00 thousand​; analysts expected $1.24
million. 
    * Singular Genomics Systems Inc's reported EPS for the
quarter was
a loss of 33 cents​.
    * The mean earnings estimate of analysts had risen by
about 4.3%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates 
    * Singular Genomics Systems Inc shares had fallen by 13.2%
this
quarter and lost 47.8% so far this year.
    * The company reported a quarterly loss of $23.63 million.
    * Wall Street's median 12-month price target for Singular
Genomics
Systems Inc is $2.25 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
9 at 10:36 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.35          -0.33          Beat
 Dec. 31 2022      -0.43          -0.29          Beat
 Sep. 30 2022      -0.41          -0.33          Beat
 Jun. 30 2022      -0.38          -0.34          Beat